Evidence map›Paper›PMID 31861116›Full record

ArticleCancers2019

Tanja Radic, Vesna Coric, Zoran Bukumiric, Marija Pljesa-Ercegovac, Tatjana Djukic, Natasa Avramovic, Marija Matic, Smiljana Mihailovic, Dejan Dragicevic, Zoran Dzamic and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Polymorphisms inLife (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tanja RadicInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.
Vesna CoricInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.
Zoran BukumiricFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Marija Pljesa-ErcegovacInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.
Tatjana DjukicInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.
Natasa AvramovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Marija MaticInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.
Smiljana MihailovicClinic for Gynecology and Obstetrics "Narodni front", 11000 Belgrade, Serbia.
Dejan DragicevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Zoran DzamicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Tatjana SimicInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.ORCID 0000-0001-8683-5129
Ana Savic-RadojevicInstitute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.ORCID 0000-0002-2026-4180
University of Belgrade · RSSerbian Academy of Sciences and Arts · RS

Funding

Serbian Ministry of Education, Science and Technological Development 175052
6 · The paper itself

Abstract

Omega class glutathione transferases, GSTO1-1 and GSTO2-2, exhibit different activities involved in regulation of inflammation, apoptosis and redox homeostasis. We investigated the the prognostic significance of

Indexed as

glutathione transferase omega 1glutathione transferase omega 2IL-1βPI3K/Akt/mTORpolymorphismpro-IL-1βRaf/MEK/ERK

Identifiers

PMID31861116
PMCPMC6966599
OpenAlexW2995207827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.